Neuberger Berman Group
MRVI icon

Neuberger Berman Group’s Maravai LifeSciences MRVI Stock Holding History

Neuberger Berman Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.3K Buy
14,625
+3,425
+31% +$14.8K ﹤0.01% 2254
2026
Q1 		$31.7K Buy
11,200
+7
+0.1% +$24 ﹤0.01% 2130
2025
Q4 		$36.4K Buy
+11,193
New +$37.7K ﹤0.01% 2070
2025
Q3 		– Sell
-11,782
Closed -$28.4K – 2112
2025
Q2 		$28.4K Buy
+11,782
New +$24.8K ﹤0.01% 2011

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Neuberger Berman Group's MRVI Position: Q2 2026 in Review

Neuberger Berman Group increased its Maravai LifeSciences (MRVI) stake by 31% in Q2 2026, buying an estimated $14.8K and bringing the position to 14,625 shares worth $91.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Neuberger Berman Group first reported a position in MRVI in Q2 2025 and has held it in 4 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Neuberger Berman Group held 14,625 shares of Maravai LifeSciences worth $91.3K as of Q2 2026.
  • Neuberger Berman Group bought 3,425 Maravai LifeSciences shares in Q2 2026, an estimated $14.8K.
  • Maravai LifeSciences made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2254 holding.
  • Neuberger Berman Group first reported a position in Maravai LifeSciences in Q2 2025 and has held it in 4 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.